Filed before 2025Filed 7 June 2022
Mytide Therapeutics, Inc. has sold $7.07M so far
Mytide Therapeutics, Inc., a biotech company based in Boston, MA, has sold $7.07M so far in its equity round, according to a filing dated 7 June 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 7 June 2022
- Round
- Equity round (amended filing)
- Amount sold
- $7.07M
- Offering size
- $7.07M
- Investors so far
- 23
- Based in
- Boston, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 45% of the 1,764 tracked raises with an amount filed in 2022, and than 39% of the 142 in biotech.
Mytide Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 6 Jan 2023 | New filing | $1.16M | Another raise |
| 7 Jun 2022 | Amended filing | $7.07M | This raise |
More with 82VS QP on the board
- Human Biotech, Inc.$10M
- Angiex, Inc.$22M
- Wheeler Bio, Inc.$23.1M
- Aakha Biologics, Inc.$750K
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.